Stay updated on Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study record for copanlisib combined with nivolumab in advanced solid tumors is displayed, including its completed status, eligibility criteria, locations, treatment plan, and outcome measures.
    Difference
    52%
    Check dated 2026-11-07T12:12:12.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T12:49:38.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T12:28:47.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The site's displayed revision changed from v3.7.1 to v3.7.2; the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T13:38:57.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T13:21:41.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is shown, replacing the study record with a standard header and footer around an error message.
    Difference
    18%
    Check dated 2026-09-19T18:30:39.000Z thumbnail image

Stay in the know with updates to Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial page.